Assessment of liver elastography as a monitoring tool for dilation therapy effectiveness in primary sclerosing cholangitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035993

Enrollment

Registered

2025-02-19

Start date

2025-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K83.00 primarily sclerosing cholangitis

Interventions

Group 1: Patients diagnosed with primary sclerosing cholangitis before and after biliary dilation therapy during ERCP

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with PSC, of ??legal age, patients who have received a FibroScan/shear wave elastography as part of their biliary dilation therapy

Exclusion criteria

Exclusion criteria: Pregnancy, LTX, other differential diagnostic diseases

Design outcomes

Primary

Measure	Time frame
Proof of the benefit of elastography for non-invasive follow-up	—

Secondary

Measure	Time frame
positive effects on laboratory parameters	—

Countries

Germany

Contacts

Public ContactJulia Kälsch

Universitätsklinkum Essen, Klinik für Gastroenterologie, Hepatologie und Tranplantationsmedizin

Julia.Kaelsch@uk-essen.de+49 201 723 3611

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026